Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 23, 2022 / 03:15PM GMT
Release Date Price: €98.5 (-1.99%)
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst

This is Paul Knight, analyst at KeyBanc on the life science market. We've had a lot of discussions over bioproduction in the life science markets over the last 1.5 days. With us today, we have Bio-Techne. David Clair will be joining us and Will Geist. You are here, you're ready to go. If you could do an intro and some opening comments, that would be great.

William A. Geist
Bio-Techne Corporation - President of Protein Sciences Segment

Yes. Thanks so much, Paul. So I'm Will Geist. I'm President of the Protein Sciences segment here at Bio-Techne. Started January 3. And kind of my purview is currently in that group, the proteomic research reagents and analytical tools. Those fit into a couple of different divisions, our Reagent Solutions Division and our Analytical Solutions Division. So really looking forward to the discussion today. And let's have at it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot